Since CCR8 was shown to be expressed by tumor cells in cutaneous T-cell lymphoma and by tumor-infiltrating Tregs in tumors, targeting CCR8-expressing cells may be a useful strategy to treat cutaneous T-cell lymphoma. Here, CCR8 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.